ClinicalTrials.Veeva

Menu
M

Meenakshi Mission Hospital and Research Centre | Clinical Research Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Paclitaxel
Trastuzumab
Dexamethasone
Cisplatin
MEZIVd
PF-05280014
Cyclophosphamide
P276-00
Mezigdomide
PVd

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 7 total trials
Locations recently updated

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (SUCCESSOR-1)

The purpose of this study is to compare the efficacy and safety of mezigdomide (CC-92480), bortezomib and dexamethasone (MeziVd) versus pomalidomide,...

Enrolling
Relapsed or Refractory Multiple Myeloma
Drug: Pomalidomide
Drug: mezigdomide

Trial sponsors

P
Boston Scientific logo
C
Celgene logo
Pfizer logo
Puma Biotechnology logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems